Zynex, Inc. Stock News

Zynex Inc (NASDAQ:ZYXI) COO Anna Lucsok shared insights earlier this week about the company's operational strategies and future growth plans in an interview with Proactive. Lucsok discussed the company's strong performance in sales and reimbursement, as well as its mission to provide non-opioid pain management solutions.

Zynex Inc (NASDAQ:ZYXI) continues to expand its portfolio of innovative, non-invasive medical devices targeting pain management, rehabilitation, and pain monitoring.   The company's flagship NexWave product is a multi-modality electrotherapy device that combines various therapeutic modalities to provide effective pain relief.

Zynex Inc (NASDAQ:ZYXI) has announced a new partnership with Veterans Affairs Medical Centers (VAMCs) across the United States, a significant opportunity to expand the reach of its noninvasive medical devices for pain management and rehabilitation. This collaboration provides an opportunity to expand sales of Zynex's pain management solutions within the largest healthcare network in the US, whi...

VA Spending on Hospital and Medical Care Exceeds $112 Billion Annually ENGLEWOOD, Colo. , Dec. 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced a new partnership t...

Zynex Inc (NASDAQ:ZYXI) CEO Thomas Sandgaard spoke with Proactive about the company's 2024 achievements and plans for 2025. Zynex reached $200 million in revenue while staying profitable, thanks to employee dedication and innovative pain management products like braces and cold therapy devices.

Zynex Inc (NASDAQ:ZYXI) announced findings from study demonstrating that its NiCO laser pulse oximeter eliminates the impact of skin pigmentation on blood oxygenation (SpO2) measurements. The University of California, San Francisco-led study compared Zynex's NiCO device to conventional LED-based pulse oximeters.

ENGLEWOOD, Colo. , Dec. 12, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced highlights from a recent study comparing its NiCO™ laser pulse oximeter to conventional LE...

ENGLEWOOD, Colo. , Dec. 5, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has completed its clinical verification trial for their NiCO™ pulse oximeter overse...